Posted On: 11/22/2014 1:59:44 PM
Post# of 30066
Didn't I hear that the injections for Wolfman's would be every six months? Not bad at all.
We need to know if AFIRM (DOD) will be issuing the grant to AMBS for ESS, if so that would be great. Pumps $17mill in equity.
The other thing with completing the study for Lympro, the results will be disclosed next month if they will use Version 1 or 2. Which one is preferred, and since we are a "Holding Company" what next, the chart said 1st quarter of 2015.
Lastly, did anyone hear what was said and who was at the "Cure" conference in New York last week?
All of my thinking is as good as anyone else here, because we all don't have a clue what ABMS is doing, the ESS acquisition with the DD for 18 months proves it.
We need to know if AFIRM (DOD) will be issuing the grant to AMBS for ESS, if so that would be great. Pumps $17mill in equity.
The other thing with completing the study for Lympro, the results will be disclosed next month if they will use Version 1 or 2. Which one is preferred, and since we are a "Holding Company" what next, the chart said 1st quarter of 2015.
Lastly, did anyone hear what was said and who was at the "Cure" conference in New York last week?
All of my thinking is as good as anyone else here, because we all don't have a clue what ABMS is doing, the ESS acquisition with the DD for 18 months proves it.
(0)
(0)
